EQS-Ad-hoc: Alzchem Group AG / Key word(s): Share Buyback Trostberg, November 5, 2024 – The Management Board of Alzchem Group AG has resolved, with the approval of the Supervisory Board, to buy back up to 100.000 shares in the company via the stock exchange for a total purchase price of up to EUR 6 million (excluding transaction costs) over a period of up to 12 months from December 2024. The buyback is for the purpose of (i) using the acquired shares as acquisition currency, (ii) issuing them to employees of the Alzchem Group or (iii) redeeming the shares. Other legally permissible purposes are not excluded. The buyback will be carried out in accordance with the provisions of the authorization of the Annual General Meeting 2024 and the Delegated Regulation (EU) 2016/1052. Further details of the buyback will be announced separately immediately before its commencement.
End of Inside Information
05-Nov-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 2022951 |
End of Announcement | EQS News Service |
|
2022951 05-Nov-2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.